ResearchIn-Press PreviewAIDS/HIVImmunology
Open Access |
10.1172/jci.insight.202628
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Gallego-Cortés, A. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Grau-Expósito, J. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Mota-Gómez, I. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Benitez-Martinez, A. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Castellvi, J. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Navarro, J. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Curran, A. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Burgos, J. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by
Suanzes, P.
in:
PubMed
|
Google Scholar
|
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Falcó, V. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by Genescà, M. in: PubMed | Google Scholar
1Infectious Diseases Department, Universitat Autònoma de Barcelona, Barcelona, Spain
2Department of Pathology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Find articles by
Buzon, M.
in:
PubMed
|
Google Scholar
|
Published July 21, 2026 - More info
Myeloid-Derived Suppressor Cells (MDSCs) represent a heterogeneous population of immature myeloid cells with potent immunosuppressive capabilities that contribute to viral persistence in chronic infections. However, their direct impact on the latent HIV reservoir remains poorly understood. Here, we report that people with HIV (PWH) exhibit elevated levels of MDSCs with notable immunosuppressive activity. Both granulocytic (G-MDSCs) and monocytic (M-MDSCs) subsets expressing arginase 1 (ARG1) or indoleamine 2,3-dioxygenase (IDO) are increased during treated infection, with low-level viral transcription preferentially associated with the expansion of highly suppressive G-MDSCs. Functional assays revealed that G-MDSCs robustly inhibit HIV reactivation from latent reservoirs. Mechanistically, G-MDSCs mediate this inhibition through a contact-independent mechanism, primarily involving ARG1 activity. Our findings demonstrate the capacity of G-MDSCs to sustain HIV reservoirs, suggesting that targeting these cells could potentiate therapeutic strategies aimed at eliminating HIV reservoirs through viral reactivation.